ADILNASANOVEL Trademark

Trademark Overview


On Wednesday, July 20, 2005, a trademark application was filed for ADILNASANOVEL with the United States Patent and Trademark Office. The USPTO has given the ADILNASANOVEL trademark a serial number of 79016130. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, July 21, 2015. This trademark is owned by SANOVEL Ilaç Sanayi ve Ticaret Anonim Sirketi. The ADILNASANOVEL trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL AND VETERINARY PREPARATIONS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS, SKELETO-MUSCULAR DISORDERS, GENERAL INFECTIONS, VIRAL INFECTIONS, CENTRAL NERVOUS SYSTEM DISORDERS, GASTRO-INTESTINAL DISORDERS, FUNGAL DISEASES, ERECTILE DYSFUNCTION, RESPIRATORY DISEASES, ALLERGY, OPHTHALMIC DISEASES, CONTAINING ONE OR MORE OF THE FOLLOWING ACTIVE INGREDIENTS - CROMOLIN SODIUM, AMLODIPIN BESYLATE, ALENDRONATE SODIUM, CHLORAZEPATE DIPOTASSIUM ATROPINE SULPHATE, ATORVASTATIN CALCIUM, CANDESARTAN CILEXETIL, CEFTRIAXONE SODIUM, EPHEDRINE HCL, GUAIPHENESINE, ZAFIRLUKAST, DONEPEZIL HCL, DIFLUNISAL, DIPYRIDAMOLE, FAMOTIDINE, LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE, MELOXICAM, PHENYLEPRINE HCL, FEXOFENADINE HCL, INDAPAMIDE, SULFISOXAZOLE, CLOPIDOGREL, LANSOPRAZOLE, CLARITHROMYCIN, FLURBIPROFEN, NIMESULIDE, PANTOPRAZOLE, PARACETAMOLE, PILOCARPINE HCL, LISINOPRIL, PSEUDO-EPHEDRINE HCL, CIPROFLOXACIN HCL, SERTRALINE HOL, CYCLOPENTOLATE HCL, DIHYDROERGOTOXINE METHANSULFONATE, TERBINAFINE, T...
adilnasanovel

General Information


Serial Number79016130
Word MarkADILNASANOVEL
Filing DateWednesday, July 20, 2005
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, July 21, 2015
Registration Number3202340
Registration DateTuesday, January 23, 2007
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, November 7, 2006

Trademark Statements


Goods and ServicesPHARMACEUTICAL AND VETERINARY PREPARATIONS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS, SKELETO-MUSCULAR DISORDERS, GENERAL INFECTIONS, VIRAL INFECTIONS, CENTRAL NERVOUS SYSTEM DISORDERS, GASTRO-INTESTINAL DISORDERS, FUNGAL DISEASES, ERECTILE DYSFUNCTION, RESPIRATORY DISEASES, ALLERGY, OPHTHALMIC DISEASES, CONTAINING ONE OR MORE OF THE FOLLOWING ACTIVE INGREDIENTS - CROMOLIN SODIUM, AMLODIPIN BESYLATE, ALENDRONATE SODIUM, CHLORAZEPATE DIPOTASSIUM ATROPINE SULPHATE, ATORVASTATIN CALCIUM, CANDESARTAN CILEXETIL, CEFTRIAXONE SODIUM, EPHEDRINE HCL, GUAIPHENESINE, ZAFIRLUKAST, DONEPEZIL HCL, DIFLUNISAL, DIPYRIDAMOLE, FAMOTIDINE, LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE, MELOXICAM, PHENYLEPRINE HCL, FEXOFENADINE HCL, INDAPAMIDE, SULFISOXAZOLE, CLOPIDOGREL, LANSOPRAZOLE, CLARITHROMYCIN, FLURBIPROFEN, NIMESULIDE, PANTOPRAZOLE, PARACETAMOLE, PILOCARPINE HCL, LISINOPRIL, PSEUDO-EPHEDRINE HCL, CIPROFLOXACIN HCL, SERTRALINE HOL, CYCLOPENTOLATE HCL, DIHYDROERGOTOXINE METHANSULFONATE, TERBINAFINE, TIMOLOL MALEATE, TIAMPHENICOL, AZITHROMYCIN, TENOXICAM, FLUCONAZOLE, DIGOXINE, TIOCONAZOLE, DIMENHYDRINATE, QUINIDINE ABOGALACTANE SULPHATE, QUINIDINE PHENYLETHYL BARBITURATE, DILTIAZEM HCL, BUSPIRONE HCL, AMIODARONE HCL, TRAZODONE, DIFLUPREDNATE, ENOXACIN, LACTULOSE, KETOROLAC, PENTOXIFYLLINE, VITAMIN E, CHLORHEXIDINE, CETRIMIDE, PROPYPHENAZONE, CAFFEINE, CETIRIZINE, PHENYLPROPANOLAMINE, ZOLPIDEM, BACAMPICILLIN HCL, ROXITHROMYCIN, SULTAMICILLIN TOSILATE, ACETYLSALICYLIC ACID, AMPICILLIN NA, SULBACTAM NA, SILDENAFIL CITRATE, AMBROXOL HCL, RIBAVIRIN, LORATADINE, ETODOLAC, OMEPRAZOLE, OXYBUTYNIN CHLORIDE, QUINIDINE SULPHATE, OLANZAPINE, RALOXIFEN, PIOGLITAZONE, MOXIFLOXACIN, ROSIGLITAZONE, SIBUTRAMIN, CARVEDILOL, MONTELUKAST, CITALOPRAM, GLICLAZIDE, CEFACLOR, EZETIMIBE, ROFECOXIB, QUETIAPINE FUMARATE, METFORMIN HCL, ACARBOSE, CHLORPHENIRAMINE MALEATE, NATEGLINIDE, LEFLUNOMIDE, VALSARTAN, CEFAZOLIN SODIUM, DIACEREIN, PAROXETINE, LEVOFLOXACIN, LEVETIRACETAM, ZOLMITRIPTAN, GLIBENCLAMIDE, TIZANIDINE, PERINDOPRIL ERBUMINE, RAMIPRIL, CEFTAZIDIME, CEFUROXIME AXETYL, THIOCOLCHICOSIDE, ACAMPROSATE, ACETYLCYSTEINE, ALPHA CALCIDOL, ALPHA LIPOIC ACID, ARIPIPRAZOLE, ATOMOXETINE, BALSALAZIDE DISODIUM, BUTENAFINE HCL, CALCITRIOL, CARBONYL IRON, FOLIC ACID, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, CEFDINIR, CEFEPIME HCL, CEFIXIME, CEFPODOXIME PROXETIL, CEFPROZIL, CEPHALEXINE MONOHYDRATE, CICLESONIDE, CILAZAPRIL, CILOSTAZOL, CINITAPRIDE, CITICOLINE, CO-ENZYME Q1O, DARIFENASIN, DEFERIPRONE, DOTHIEPIN, DULOXETINE, ELETRIPTAN, ESCITALOPRAM, ESOMEPRAZOLE, ETORICOXIB, FELODIPINE, FENOFIBRATE, FERROUS SULPHATE, ZINC SULPHATE, FLUVASTATIN, FROVATRIPTAN, GABAPENTIN, GALANTAMINE, GEMIFLOXACIN, GINKGO BILOBA, GLIMEPRIDE, GRANISETRON, IBANDRONATE IRBESARTAN, IRON HYDROXIDE POLYMALTOSE, LAMIVUDINE, LAMOTRIGINE, LEVETIRACETAM, LETROZOLE, LINEZOLIDE, MEMANTINE HCL, METOPROLOL, MIDODRINE, MIRTAZAPINE, MIZOLASTINE, MOSAPRIDE CITRATE DIHYDRATE, MYCOPHENOLATE MOFETIL, NEBIVOLOL, NEFAZODONE, NIACIN, NITAZOXANIDE, ONDANSETRON, ORNIDAZOLE, OXCARBAZEPINE, PIMECROLIMUS, PRAVASTATIN, PREGABALIN, RABEPRAZOL, REBAMIPIDE, REPAGLINIDE, RISEDRONATE, RISPERIDONE, RIVASTIGMINE, ROSUVASTATIN, SACCHAROMYCES BOULARDII, TACROLIMUS, TADALAFIL, TANSULOSIN HCL, TAZAROTEN, TAZOBACTAM SODIUM, PIPERACILLIN SODIUM, TEGASEROD, TELITHROMYCIN, TERAZOCIN, TERIPARATIDE, TOLTERODINE TARTRATE, TOPIRAMATE, TRANDOLAPRIL, TRIMETHAZIDINE, VALACYCLOVIR, VALPROATE SODIUM, VENLAFAXINE, VORICONAZOLE, XIMELAGATRAN, ZALEPLON, ZIPRASIDONE, ZOLEDRONIC ACID; SANITARY PREPARATIONS FOR MEDICAL PURPOSES; DIETETIC FOODS ADAPTED FOR MEDICAL USE; FOOD FOR BABIES; MEDICAL PLASTERS; BANDAGES FOR DRESSINGS; MATERIAL FOR STOPPING TEETH; DENTAL WAX; DISINFECTANTS; PREPARATIONS FOR DESTROYING VERMIN; FUNGICIDES, HERBICIDES

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 27, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSANOVEL ILAÇ SANAYI VE TICARET ANONIM SIRKETI
Party Type30 - Original Registrant
Legal Entity Type09 - Joint Stock Company
AddressTR

Party NameSANOVEL Ilaç Sanayi ve Ticaret Anonim Sirketi
Party Type20 - Owner at Publication
Legal Entity Type09 - Joint Stock Company
AddressTR

Party NameSANOVEL Ilaç Sanayi ve Ticaret Anonim Sirketi
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressTR

Trademark Events


Event DateEvent Description
Friday, February 5, 2016NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, February 5, 2016DEATH OF INTERNATIONAL REGISTRATION
Friday, June 5, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Saturday, November 1, 2014GENERIC MADRID TRANSACTION SENT TO IB
Saturday, November 1, 2014GENERIC MADRID TRANSACTION CREATED
Tuesday, May 27, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 27, 2013CANCELLED SECTION 71
Saturday, November 3, 2012CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, May 2, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, August 23, 2007FINAL DISPOSITION NOTICE SENT TO IB
Thursday, August 23, 2007FINAL DISPOSITION PROCESSED
Friday, August 17, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 23, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, November 7, 2006PUBLISHED FOR OPPOSITION
Wednesday, October 18, 2006NOTICE OF PUBLICATION
Wednesday, September 20, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 8, 2006ASSIGNED TO LIE
Friday, September 1, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 17, 2006AMENDMENT FROM APPLICANT ENTERED
Monday, July 24, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 24, 2006PAPER RECEIVED
Friday, July 14, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 16, 2006REFUSAL PROCESSED BY IB
Wednesday, February 22, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, February 22, 2006REFUSAL PROCESSED BY MPU
Saturday, February 18, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, February 17, 2006NON-FINAL ACTION WRITTEN
Tuesday, February 7, 2006ASSIGNED TO EXAMINER
Monday, November 7, 2005NEW APPLICATION ENTERED IN TRAM
Thursday, November 3, 2005SN ASSIGNED FOR SECT 66A APPL FROM IB